initialrecords.com

Allergan agrees $600m settlement for unapproved Botox marketing

Allergan agrees $600m settlement for unapproved Botox marketing
CHICAGO – Allergan Inc has agreed to pay $600 million to settle a federal investigation of its marketing practices for the injectable wrinkle smoother Botox.

Read more on The Irish Times

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>